Uses of keratinocyte growth factor-2
AssigneeAmgen Inc.
InventorsDavid L. Lacey, Thomas R. Ulich, Dimitry M. Danilenko, Catherine L. Farrell
Life of this patent
Estimating the term…
Abstract
The present invention concerns the use of a KGF-2 protein(s) as a therapeutic agent, suitably formulated in a pharmaceutical composition, for the specific treatment of disease states and medical conditions afflicting tissues and organs such as in the eye, ear, gums, pancreas, urinary bladder, liver and gastrointestinal tract.
Claims16
A method of stimulating the production of epithelial cells selected from the group consisting of cells within the eye, ear, gums, pancreas, urinary bladder, liver and gastrointestinal tract (e.g., cells in the oral cavity, in the glandular stomach and small intestine, in the colon, and other cells within the intestinal mucosa), comprising contacting such cells with an effective amount of a KGF-2 protein(s).
Dependencies are inferred from the claim text.